Genomill
1 known investors
Genomill develops Geno1 technologies, including Bridge Capture and Nicking Loop, for next-generation sequencing (NGS) applications used in healthcare diagnostics. Its PCR-free methods aim to detect rare mutations for uses such as early cancer detection and minimal residual disease (MRD) monitoring while lowering costs and enabling decentralized sequencing.
BiotechHealthtechMedical Devices
Investors · 1
In the news
Frequently asked questions
- What does Genomill do?
- Genomill develops Geno1 technologies, including Bridge Capture and Nicking Loop, for next-generation sequencing (NGS) applications used in healthcare diagnostics. Its PCR-free methods aim to detect rare mutations for uses such as early cancer detection and minimal residual disease (MRD) monitoring while lowering costs and enabling decentralized sequencing.
- Who are Genomill's investors?
- Genomill's investors include Voima Ventures.